Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

Antoaneta Tomova, Rupert Bartsch, Thomas Brodowicz et al. · Breast Cancer Research and Treatment · 2009

Cited by 17 works. doi:10.1007/s10549-009-0553-4

Authors

References